Results 141 to 150 of about 51,637 (256)

Ocular myasthenia gravis management. [PDF]

open access: yesFront Neurol
Kupersmith MJ, Wolfe GI, Kaminski H.
europepmc   +1 more source

Efficacy and Safety of IncobotulinumtoxinA for Treatment of Sialorrhea: A Multicenter, Phase 3 Study in Japan

open access: yesMovement Disorders Clinical Practice, Volume 13, Issue 1, Page 120-130, January 2026.
This study demonstrated significant treatment efficacy and safety of incobotulinumtoxinA injection in Japanese patients with chronic sialorrhea caused by Parkinson's disease and other neurological conditions. Suppression of salivary secretion and improvement in drooling symptoms were also observed throughout 48 weeks.
Nobutaka Hattori   +15 more
wiley   +1 more source

Amyotrophic Lateral Sclerosis Clinical Research Site Operations: Emerging Challenges and Potential Solutions From Multiple Sites in the US

open access: yesMuscle &Nerve, Volume 73, Issue 1, Page 28-33, January 2026.
As amyotrophic lateral sclerosis (ALS) clinical trials rapidly expand, efficient site operations are critical to success. A discussion among U.S. research sites identified ten practical strategies, creating a framework to strengthen infrastructure, streamline operations, and ensure sustainability of ALS clinical research sites while supporting ...
Erica Scirocco   +13 more
wiley   +1 more source

Myasthenia gravis and prostatic neoplasia: a rare association

open access: green, 2021
Mafalda Sá Pereira   +3 more
openalex   +2 more sources

Prevalence and Geographical Distribution of Patients With Congenital Myasthenic Syndromes in the United Kingdom

open access: yesMuscle &Nerve, Volume 73, Issue 1, Page 79-85, January 2026.
ABSTRACT Introduction/Aims Congenital myasthenic syndromes (CMS) are often underdiagnosed due to phenotypic overlap with other neuromuscular disorders. Limited epidemiological data and low awareness hinder early diagnosis, which is key for effective treatment.
Elena Rossini   +10 more
wiley   +1 more source

Mitochondrial proteins contribute to the pathogenesis of myasthenia gravis. [PDF]

open access: yesSci Rep
Cao F   +7 more
europepmc   +1 more source

Juvenile Ocular Myasthenia Gravis in a 3-Year-Old African Girl: A Case Report

open access: gold
Elisamia Ngowi   +8 more
openalex   +1 more source

Home - About - Disclaimer - Privacy